MAPT and frontotemporal dementia: Pathological studies have shown the deposition of abnormal proteins in the brain tissues of FTD patients, including TDP-43 (50% of cases), tau (40% of cases), and FUS (5–10% of cases).314,315 Gene mutation is an important pathogenic factor for FTD.